Arrowhead Research reported $31.62M in Selling and Administration Expenses for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Agios Pharmaceuticals AGIO:US USD 29.12M 859K
Alnylam Pharmaceuticals ALNY:US USD 235.86M 65.88M
Anika Therapeutics ANIK:US USD 21.28M 8K
Arrowhead Research ARWR:US USD 31.62M 1.11M
Bluebird Bio BLUE:US USD 33.4M 3.29M
Heron Therapeutics HRTX:US USD 28.18M 3.94M
Intercept Pharmaceuticals ICPT:US USD 43.27M 3.29M
IONIS PHARMACEUT IONS:US USD 34.42M 614K
Ligand Pharmaceuticals LGND:US USD 17.44M 2.86M
Merk MRK:US USD 2.47B 13M
Mirati Therapeutics MRTX:US USD 60.8M 6.57M
Moderna Inc MRNA:US USD 278M 67M
Nektar Therapeutics NKTR:US USD 22.53M 1.09M
Novartis NOVN:VX USD 3.4B 185M
Opko Health OPK:US USD 79.67M 21.79M
Sarepta Therapeutics SRPT:US USD 104.79M 49.53M
Spectrum Pharmaceuticals SPPI:US USD 8.26M 1.12M
Tg Therapeutics TGTX:US USD 14.25M 1.62M
Ultragenyx Pharmaceutical RARE:US USD 69.84M 1.7M
Vertex Pharmaceuticals VRTX:US USD 246.8M 31.5M
Xencor XNCR:US USD 12.37M 1.28M
YTE INCY:US USD 266.46M 13.18M